These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy. Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618 [TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002 [TBL] [Abstract][Full Text] [Related]
4. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR. Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176 [TBL] [Abstract][Full Text] [Related]
5. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy. Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Lashkari K; Rahimi N; Kazlauskas A Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438 [TBL] [Abstract][Full Text] [Related]
8. The role of thrombin in proliferative vitreoretinopathy. Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. El-Ghrably IA; Dua HS; Orr GM; Fischer D; Tighe PJ Br J Ophthalmol; 2001 Apr; 85(4):461-70. PubMed ID: 11264138 [TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248 [TBL] [Abstract][Full Text] [Related]
11. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911 [TBL] [Abstract][Full Text] [Related]
12. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976 [TBL] [Abstract][Full Text] [Related]
14. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis in proliferative vitreoretinopathy. El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604 [TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518 [TBL] [Abstract][Full Text] [Related]
17. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade. Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070 [TBL] [Abstract][Full Text] [Related]
19. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy. Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407 [TBL] [Abstract][Full Text] [Related]